Post Marketing Observational Study on Safety of BALFAXAR vs. KCENTRA for Reversal of Vitamin K Antagonist Induced Anticoagulation in Adults Undergoing Urgent Surgery or Invasive Procedure - Clinical Trial NCTNCT06429787
Business Opportunities for NCT06429787
Connect with principal investigators, study coordinators, and key decision makers for this clinical trial studying investigational therapy for Vitamin K-Dependent Coagulation Defect, Significant Bleeding Risk.
Clinical Trial Information
- Study Sponsor
- Sponsor information available
- Drug/Intervention
- Study intervention details available
- Therapeutic Area
- Hemostatic Disorders, Blood Coagulation Disorders
- Study Phase
- Phase information available
- Study Status
- RECRUITING
- NCT Number
- NCTNCT06429787
Find Contact Information
Access exclusive contact details for:
- Principal investigators and sub-investigators
- Study coordinators and research staff
- Site directors and facility contacts
- Sponsor representatives and CRO partners
- Business development professionals
- Clinical operations managers
Clinical Trial Locations
This study has 1 locations across United States.
Study Site
Boston, Massachusetts United States
Why Choose Quri.ai Study Finder
Quri.ai's Study Finder is the leading clinical trial business intelligence platform, helping BD professionals:
- Discover clinical trials before competitors
- Access exclusive contact information
- Track sponsor pipelines and opportunities
- Connect with decision makers directly
- Win more business partnerships